Growth Metrics

Astrana Health (ASTH) Non Operating Investment Income (2016 - 2025)

Astrana Health (ASTH) has disclosed Non Operating Investment Income for 10 consecutive years, with $769000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Investment Income rose 143.35% to $769000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$68000.0 through Dec 2025, down 109.3% year-over-year, with the annual reading at -$68000.0 for FY2025, 109.3% down from the prior year.
  • Non Operating Investment Income hit $769000.0 in Q4 2025 for Astrana Health, up from -$807000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $83.8 million in Q2 2021 to a low of -$60.9 million in Q3 2021.
  • Historically, Non Operating Investment Income has averaged -$1.9 million across 5 years, with a median of -$342000.0 in 2023.
  • Biggest five-year swings in Non Operating Investment Income: skyrocketed 146.03% in 2023 and later plummeted 114.32% in 2024.
  • Year by year, Non Operating Investment Income stood at -$33.6 million in 2021, then surged by 89.04% to -$3.7 million in 2022, then skyrocketed by 135.16% to $1.3 million in 2023, then tumbled by 75.58% to $316000.0 in 2024, then skyrocketed by 143.35% to $769000.0 in 2025.
  • Business Quant data shows Non Operating Investment Income for ASTH at $769000.0 in Q4 2025, -$807000.0 in Q3 2025, and $14000.0 in Q2 2025.